| 2ICA: Cd11a (Lfa1) I-Domain Complexed With Bms-587101 Aka 5-[(5s, Cyanophenyl)-3-(3,5-Dichlorophenyl)-1-Methyl-2,4-Dioxo-1,3, Triazaspiro [4.4]Non-7-Yl]Methyl]-3-Thiophenecarboxylicacid reference: Discovery and development of 5-[(5S,9R)-9- (4-cyanophenyl)-3-(3,5-dichlorophenyl)-1- methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non- 7-yl-methyl]-3-thiophenecarboxylic acid (BMS-587101)--a small molecule antagonist leukocyte function associated antigen-1., Potin D, Launay M, Monatlik F, Malabre P, Fabreguettes M, Fouquet A, Maillet M, Nicolai E, Dorgeret L, Chevallier F, Besse D, Dufort M, Caussade F, Ahmad SZ, Stetsko DK, Skala S, Davis PM, Balimane P, Patel K, Yang Z, Marathe P, Postelneck J, Townsend RM, Goldfarb V, Sheriff S, Einspahr H, Kish K, Malley MF, DiMarco JD, Gougoutas JZ, Kadiyala P, Cheney DL, Tejwani RW, Murphy DK, Mcintyre KW, Yang X, Chao S, Leith L, Xiao Z, Mathur A, Chen BC, Wu DR, Traeger SC, McKinnon M, Barrish JC, Robl JA, Iwanowicz EJ, Suchard SJ, Dhar TG, J Med Chem. 2006 Nov 30;49(24):6946-9. PMID: 17125246 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).